Press release
Migraine Drugs Market (by Type and Applications ): Insights and Forecast with Potential Impact of COVID-19 (2021-2030)
Migraine is a medical condition pertaining with primary headache disorder with symptoms such as nausea, vomiting, dry mouth, somnolence, and sensitivity to light or sound. The headaches start from one side of the head and are pulsating in nature. In some cases, patients are affected by prevalence of aura. The recurrent headaches can last up to some hours or days, with intensity varying from moderate to severe. Migraine has no permanent cure, but migraine drugs can be used to reduce and prevent migraines.
Access Full Description of this report at:-
https://www.nextmsc.com/report/migraine-drugs-market
Top Companies: Allergan Plc, Abbott Laboratories, AstraZeneca, Endo International Plc., Eisai Co. Ltd., Impax Laboratories, GlaxoSmithKline Plc., Johnson & Johnson, Pfizer Inc., Merck & Co., Teva Pharmaceutical Industries Limited, Sanofi SA and others.
According to the data provided by Migraine Trust in 2017, 1 in 7 people worldwide suffer from migraine, i.e. 2% of the total world population suffer from migraine; thereby, migraine being the third most common disease at global level. This scenario generates a demand for effective migraine drugs with minimal or no side-effects; hence supplementing the growth of migraine drugs market. However, side effects associated with the intake of migraine drugs are expected to restrict the growth of migraine drugs market.
Request sample copy of this report at:-
https://www.nextmsc.com/Migraine-Drugs-Market/request-sample
The global migraine drugs market share has been analyzed based on type, route of administration, distribution channel and geography. Based on type, the migraine drugs market is segmented into preventive medicine and abortive medicine. The abortive medicine segment is sub segmented into Triptans (Serotonin Receptor Agonists), Ergotamine Derivative, and others. The preventive medicine is further divided into Anticonvulsant, Antidepressant, Beta Blocker, and others. Based on distribution channel, the migraine drugs market is divided into hospital-based pharmacies, retail pharmacies, and online pharmacies. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
Postal Address:
2/90/A, Azadgarh, Regent Park, Kolkata, West Bengal, India, 700040
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com
About Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
For more insights, please visit, https://www.nextmsc.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market (by Type and Applications ): Insights and Forecast with Potential Impact of COVID-19 (2021-2030) here
News-ID: 2421532 • Views: …
More Releases from Next Move Strategy Consulting
Acne Medication Market Set for Exponential Growth with a Projected 3.2% CAGR by …
Introduction:
According to the Next Move Strategy Consulting, the Global Acne Medication Market size is anticipated to reflect a Compound Annual Growth Rate (CAGR) of 3.2% from 2024 to 2030.
The acne medication market is experiencing a transformative surge, driven by the increasing demand for effective solutions to address skincare concerns globally. As individuals prioritize skincare and beauty, the acne medication market emerges as a key player in providing innovative, targeted…
Unleashing the Potential of the Hemodialysis Market for Unprecedented Growth wit …
According to the Next Move Strategy Consulting, the Global Hemodialysis Market size is anticipated to reflect a Compound Annual Growth Rate (CAGR) of 3.60% from 2024 to 2030.
In recent years, the global healthcare landscape has witnessed a significant surge in demand for advanced renal care solutions, with the hemodialysis market emerging as a pivotal player in addressing the evolving needs of patients grappling with kidney-related issues.
Projections indicate that…
Managed Mobility Services Market Accelerates Towards USD 133.90 Billion Valuatio …
In a groundbreaking revelation, industry experts at Next Move Strategy Consulting unveil a compelling trajectory for the managed mobility services market, foreseeing an exceptional valuation of USD 133.90 billion by 2030. This robust ascent is underpinned by an extraordinary CAGR of 31.1%, signifying the pivotal role managed mobility services play in reshaping the digital landscape and empowering businesses with unparalleled mobility solutions.
Introduction:
Positioned as a linchpin in the broader landscape of…
The Infant Phototherapy Device Market Set for Remarkable Growth with a Projected …
Introduction:
According to the Next Move Strategy Consulting, the Global Infant Phototherapy Device Market size is anticipated to reflect a Compound Annual Growth Rate (CAGR) of 4.0% from 2024 to 2030.
The global infant phototherapy device market is poised for unprecedented growth, driven by the increasing demand for advanced neonatal care solutions and a growing focus on improving infant health outcomes. This comprehensive analysis delves into the key drivers, market segmentation,…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
